Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 18, 2024Pediatric Blood & Cancer

A systematic literature review of clinical evidence and treatment burden in newly diagnosed high‐risk pediatric patients with classical Hodgkin lymphoma

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJamie E. FlerlageSt. Jude Children's Research HospitalCWChristine Waters‐BankerNew York City Department of Health and Mental HygieneMFMichelle A. FanalePfizer (United States)

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Flerlage et al. (2024) studied this question.

synapsesocial.com/papers/68e69710b6db64358761dd34https://doi.org/10.1002/pbc.31027
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial2021 · 32 citations
  2. 2Evaluation of the Risk of Relapse in Classical Hodgkin Lymphoma at Event-Free Survival Time Points and Survival Comparison With the General Population in British Columbia2016 · 81 citations
  3. 3Response‐adapted therapy for the treatment of children with newly diagnosed high risk Hodgkin lymphoma (AHOD0831): a report from the Children’s Oncology Group2019 · 84 citations
  4. 4Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III/IV Hodgkin lymphoma2019 · 132 citations
  5. 5Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children’s Oncology Group AHOD 1331 study2023 · 15 citations